Vaccine offered to children i Skania, Sweden, at high risk of diabetes
Children participating in the DiPiS and TEDDY studies, who are at high risk of developing type 1 diabetes, have the possibility to receive GAD vaccine. The hope is that this will stop the process and prevent the children from falling ill. Some of the children who have an increased risk of type 1 diabetes start producing antibodies directed at the insulin producing cells. This is a warning that the
https://www.ludc.lu.se/article/vaccine-offered-children-i-skania-sweden-high-risk-diabetes - 2026-01-05
